Publications by authors named "Ruixiu Wang"

Claim this Profile
sp. nov., a novel anamorphic basidiomycete yeast species.
Rui-Xiu Wang, Dan-Yang Cai, Feng-Li Hui

Int J Syst Evol Microbiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and biological evaluation of aminopyrazine derivatives as inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2).
Songnian Lin, Sunita Malkani, Matthew Lombardo, Lihu Yang, Sander G Mills, Ruixiu Wang

Bioorg Med Chem Lett· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel 1-(2-aminopyrazin-3-yl)methyl-2-thioureas as potent inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2).
Songnian Lin, Matthew Lombardo, Sunita Malkani, Jeffrey J Hale, Sander G Mills, Ruixiu Wang

Bioorg Med Chem Lett· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p38 MAP kinase inhibitors: metabolically stabilized piperidine-substituted quinolinones and naphthyridinones.
Jianming Bao, Julianne A Hunt, Shouwu Miao, Kathleen M Rupprecht, John E Stelmach, Ruixiu Wang

Bioorg Med Chem Lett· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time-resolved Forster resonance energy transfer assays for the binding of nucleotide and protein substrates to p38alpha protein kinase.
Wen Xiao Zhang, Ruixiu Wang, Douglas Wisniewski, Alice I Marcy, Philip LoGrasso

Anal Biochem· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of Janus kinase 3-catalyzed phosphorylation of a Janus kinase 1 activation loop peptide.
Ruixiu Wang, Patrick R Griffin, Eliza C Small, James E Thompson

Arch Biochem Biophys· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hybrid-designed inhibitors of p38 MAP kinase utilizing N-arylpyridazinones.
Steven L Colletti, Jessica L Frie, Elizabeth C Dixon, Suresh B Singh, Bernard K Choi, Ruixiu Wang

J Med Chem· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis